Related Experiment Videos
Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial
N H Nielsen1, G Bronfort, T Bendix
1National University Hospital (Rigshospitalet), Medical Department TTA, Allergy Unit, Copenhagen, Denmark.
Summary
Chiropractic spinal manipulation showed no significant benefit for chronic asthma patients compared to sham treatment. While lung function remained unchanged, patients reported reduced asthma severity and improved bronchial reactivity.
Area of Science:
- Integrative medicine
- Respiratory medicine
- Clinical trials
Background:
- Chronic asthma management often involves pharmaceutical therapies.
- Complementary therapies like chiropractic treatment are explored for asthma symptom relief.
Purpose of the Study:
- To evaluate the efficacy of chiropractic treatment as an adjunct to pharmaceutical maintenance therapy for chronic asthma.
- To assess chiropractic's impact on lung function, bronchodilator use, asthma severity, and bronchial reactivity.
Main Methods:
- A randomized, patient- and observer-blinded, cross-over trial involving 31 adult chronic asthma patients.
- Participants received active or sham chiropractic spinal manipulative treatment twice weekly for 4 weeks, followed by a cross-over period.
- Outcome measures included lung function (FEV1, FVC), bronchodilator use, patient-rated severity, and non-specific bronchial reactivity (n-BR).
Main Results:
- No statistically significant or clinically important differences were observed between active and sham chiropractic interventions for primary or secondary outcomes.
- Objective lung function (FEV1, FVC) did not change significantly.
- A significant improvement in non-specific bronchial hyperreactivity (n-BR) by 36% (P=0.01) and a decrease in patient-rated asthma severity by 34% (P=0.0002) were noted from baseline.
Conclusions:
- Chiropractic spinal manipulative treatment, when added to standard pharmaceutical care, did not demonstrate significant efficacy over sham treatment for chronic asthma.
- Despite no objective lung function improvement, patients experienced subjective benefits in asthma severity and bronchial reactivity.